391 - Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
391 - Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
00:00
00:00
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
No episode description available.
Published13 Jul 2026
Duration53:04
Episodes
391-
Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
Listened
13 Jul 2026
390-
Neelam Goyal, MD / Gil I. Wolfe, MD, FAAN - Spotlight on Seronegative Generalized Myasthenia Gravis: From Clinical Uncertainty to Personalized Treatment
Listened
Wed, 8 Jul 2026 18:00:00 -0500
389-
Jiwon Oh, MD, PhD, FRCPC, Gregory F. Wu, MD, PhD, FAAN - New Pathways, New Possibilities in Multiple Sclerosis: BTK Inhibition and the Future of Patient Care
Listened
Thu, 2 Jul 2026 18:00:00 -0500
388-
Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution
Listened
29 May 2026
387-
Bhavana Pothuri, MD, MS / Premal Thaker, MD, MS - Targeting With Precision in Advanced Ovarian Cancer: Integrating Approved and Novel Agents Into Personalized Treatment Plans
Listened
29 May 2026
386-
April W. Armstrong, MD, MPH - A New Era in Psoriasis Care With Oral IL-23 Inhibitors
Listened
Thu, 7 May 2026 18:00:00 -0500
385-
Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH, Richard Dang, PharmD - RSV in Focus: Pharmacists Driving Vaccine Access, Confidence, and Education
Listened
Thu, 7 May 2026 18:00:00 -0500
384-
Guy Young, MD - Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery
Listened
27 Apr 2026
383-
Olalekan Oluwole, MBBS, MPH - ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy
Listened
15 Apr 2026
382-
Haydar Frangoul, MD, MS, Akshay Sharma, MBBS, MSc - Transformative Care for Hemoglobinopathies: Guidance on the Gene Therapy Experience in SCD and Thalassemia
Listened
15 Apr 2026
381-
Philip J. Mease, MD, MACR - Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition
Listened
24 Mar 2026
380-
Seema S. Aceves, MD, PhD - Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care
Listened
Wed, 4 Mar 2026 18:00:00 -0500
379-
Anju T. Peters, MD, MS, Michael Platt, MD, MSc - Treating With Precision in CRSwNP: Defining the Role of Targeted Biologic Therapy for Optimal Patient Outcomes
Listened
24 Feb 2026
378-
Thomas Grader-Beck, MD - Beneath the Surface of Sjögren’s Disease: Understanding Systemic Impact and B-Cell–Mediated Pathways
Listened
29 Dec 2025
377-
Joseph K. Han, MD, FARS, FAAAAI - Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!
Listened
18 Dec 2025
376-
Christine Franzese, MD, FARS, Flavia C.L. Hoyte, MD, FACAAI - The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments
Listened
12 Dec 2025
375-
Nikhil I. Khushalani, MD - The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease
Listened
30 Oct 2025
374-
Aleena Banerji, MD - Improving the Care of Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis
Listened
27 Oct 2025
373-
Alexis Ogdie, MD, MSCE, Robert H. Eckel, MD, FAHA, FACC - Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health
Listened
27 Oct 2025
372-
Kathleen M. Buchheit, MD, Joseph K. Han, MD, FARS, FAAAAI - Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment
Listened
26 Sep 2025
371-
Jennifer Hsiao, MD - Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel Agents
Listened
26 Sep 2025
370-
Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs
Listened
11 Jul 2025
369-
Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies
Listened
Mon, 7 Jul 2025 18:00:00 -0500
368-
Tina Cascone, MD, PhD / Heather A. Wakelee, MD, FASCO - Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum
Listened
30 Jun 2025
367-
Arndt Vogel, MD, PhD - Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy and Targeted Platforms
Listened
27 Jun 2025
366-
Michael E. Manning, MD, FAAAAI, FACAAI - From Wheals to Wellness: Transforming Chronic Spontaneous Urticaria Care With Emerging Solutions
Listened
17 Jun 2025
365-
Anca D. Askanase, MD, MPH / Philip J. Mease, MD, MACR - An Immune Reset for Systemic Lupus Erythematosus: Expanding Therapeutic Horizons With CAR-T Cell Therapy
Listened
11 Jun 2025
364-
Hans Lee, MD - Planting Roots for Next-Gen Bispecific Antibodies in Hematologic Cancers: Collaborative Principles to Extend the Reach of Immunotherapy in Myeloma and Lymphoma
Listened
11 Jun 2025
363-
Sia Daneshmand, MD - Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum
Listened
16 May 2025
362-
Krish Patel, MD / Nirav Shah, MD, MS - The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT
Listened
Tue, 1 Apr 2025 18:00:00 -0500
361-
Michael E. Wechsler, MD - Overcoming Challenges in the Management of Severe Asthma: Expert Insights on Emerging Strategies to Close the Gaps to Optimal Care
Listened
Tue, 1 Apr 2025 18:00:00 -0500
360-
Neeraj Agarwal, MD, FASCO - Targeted Assault on mCRPC With PARPi Therapies: A VA Tactical Playbook
Listened
Tue, 1 Apr 2025 18:00:00 -0500
359-
Anna Kovalszki, MD, FAAAAI, Michael E. Wechsler, MD - Stories Behind the Science in EGPA: Updated Strategies for Diagnosis, Treatment, and Reducing the Steroid Burden in Patients
Listened
Tue, 1 Apr 2025 18:00:00 -0500
358-
Michael Levy, MD, PhD - Navigating MOGAD: Case-Based Insights Into Diagnosis, Treatment, and Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Listened
24 Mar 2025
357-
Karim Fizazi, MD, PhD - Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond
Listened
11 Mar 2025
356-
William Kitchens, MD, PhD, FACS, FAST - Improving Kidney Transplant Access and Equity With Innovative Immunosuppression Strategies
Listened
Thu, 6 Mar 2025 18:00:00 -0500
355-
Gerald Appel, MD, Dana V. Rizk, MD - Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies
Listened
Wed, 5 Mar 2025 18:00:00 -0500
354-
Ghassan Abou-Alfa, MD, JD, MBA - Accelerating Innovation In Biliary Tract Cancer: Restructuring Treatment Models With Immunotherapy and Targeted Platforms In Advanced Disease
Listened
24 Feb 2025
353-
John V. Bosso, MD, FAAAAI - Mastering the Art and Science of Biologic Therapy for CRSwNP: Who Are the Candidates and How Do You Manage Their Care?
Listened
17 Feb 2025
352-
Amy J. McMichael, MD - From Roots to Results: Elevating Alopecia Areata Management
Listened
28 Jan 2025
351-
Professor Claire Harrison, DM - Mastering the Art of Myelofibrosis Care: Expert Guidance, Clinical Experience, and Innovation for More Personalized Disease Control
Listened
Mon, 6 Jan 2025 18:00:00 -0500
350-
Elena Castro, MD, Karim Fizazi, MD, PhD - What’s Around the Corner in Advanced Prostate Cancer? Candid Conversations to Future Proof Your Practice for Targeted Therapies
Listened
27 Dec 2024
349-
Shannon N. Westin, MD, MPH, Ramez N. Eskander, MD - Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine: How to Translate Clinical Evidence Into Meaningful Improvements for Patients
Listened
Wed, 2 Oct 2024 18:00:00 -0500
348-
Naval Daver, MD, Tapan Kadia, MD - Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics
Listened
Wed, 2 Oct 2024 18:00:00 -0500
347-
Praveen Akuthota, MD - Recognizing the Burden of Patients Living With EGPA: An Exploration of Best Practices in Diagnosis and Treatment in the Context of a Multidisciplinary Approach
Listened
30 Jul 2024
346-
Maissaa Janbain, MD, MSCR - Clotting the Gaps in VWD Care: Elevating Diagnostic Awareness and Treatment Planning With Modern Therapeutic Approaches
Listened
18 Jul 2024
345-
Geoffrey L. Chupp, MD / Autumn Burnette, MD, FACAAI - Leveraging the Power of Targeted Biologic Therapy in Severe Asthma: Do You Know How and For Whom?
Listened
Thu, 4 Jul 2024 18:00:00 -0500
344-
Prof. Mohamad Mohty, MD, PhD - Expanding Frontline Frontiers in MM: Insights on Delivering Modern Care With Innovative CD38 Quadruplet Platforms
Listened
Wed, 3 Jul 2024 18:00:00 -0500
343-
Petros Grivas, MD, PhD - On Target: Integrating Trop-2-Directed Therapeutics for Urothelial Carcinoma With Precision
Listened
Wed, 3 Jul 2024 18:00:00 -0500
342-
Ruben A. Mesa, MD, FACP - CONTROL Myelofibrosis: Current Options, New Treatment Principles, and Opportunities to Leverage JAKi Platforms and Novel MOAs